Share Name Share Symbol Market Type Share ISIN Share Description
Indivior Plc LSE:INDV London Ordinary Share GB00BRS65X63 ORD USD0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.80 -0.62% 129.10 128.80 129.20 132.80 128.90 132.80 54,218 08:51:34
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 591.9 135.7 13.6 9.6 947

Indivior PLC Appointment of Chief Financial Officer

20/11/2020 11:30am

UK Regulatory (RNS & others)

Indivior (LSE:INDV)
Historical Stock Chart

From Oct 2020 to Nov 2020

Click Here for more Indivior Charts.


RNS Number : 0258G

Indivior PLC

20 November 2020

Indivior PLC - Appointment of Chief Financial Officer

Slough, UK, and Richmond, VA, November 20, 2020 - The Board of Directors of Indivior PLC are pleased to announce the appointment of Ryan Preblick as Chief Financial Officer and Executive Director with immediate effect.

Ryan has been serving as Interim Chief Financial Officer since June 2020 and has been in financial leadership roles since joining Indivior in 2012. Prior to his appointment as Interim Chief Financial Officer in June 2020, Ryan was Senior Vice President, Global Financial Planning and Analysis Commercial Operations. This role included overseeing all key financial management, analysis and reporting elements of the Group's global business. Prior to that, Ryan was Vice President, US Finance with responsibility overseeing all financial areas of the US business, the Group's largest business, including management, planning, analysis and reporting, government pricing and managed care contracting operations.

Ryan started his career in corporate finance at Honeywell International and then spent twelve years at Altria Company (including Philip Morris USA) in finance leadership roles of increasing responsibility working with Treasury, Financial Planning & Analysis, Market Analytics, Supply Chain and Brand Decision Support. Ryan holds a BS in Finance from Penn State University and an MBA from the University of Richmond.

Comment by Mark Crossley, Chief Executive Officer

Ryan has proven to be a highly capable leader of our finance organization and has performed strongly in his role as Interim Chief Financial Officer. The Board and I are delighted to confirm his appointment as Chief Financial Officer and Executive Director.

The Company confirms there is no further information to be disclosed pursuant to LR 9.6.13 in connection with Ryan Preblick's appointment.

About Indivior

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease.

Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 700 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit to learn more. Connect with Indivior on LinkedIn by visiting .

Investor Contact :

Jason Thompson, Indivior

Vice President, Investor Relations

+1 804-402-7123

Media Contacts :


Tulchan Communications

+44 207-353-4200


+1 804-594-0836


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

November 20, 2020 06:30 ET (11:30 GMT)

1 Year Indivior Chart

1 Year Indivior Chart

1 Month Indivior Chart

1 Month Indivior Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201125 09:11:08